Rongyu Zang

Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

Andreas du Bois, Anne Floquet, Jae‐Weon Kim et al. · Journal of Clinical Oncology · 2014 · 318 citations · Full text

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

Michelle Wilson, Éric Pujade-Lauraine, Daisuke Aoki et al. · Annals of Oncology · 2016 · 285 citations · Full text

Gynecological Surgery, Medicine, Gynecologic Cancer Intergroup +8

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

Tingyan Shi, Jianqing Zhu, Yanling Feng et al. · The Lancet Oncology · 2021 · 211 citations

Chemotherapy Versus Chemotherapy, Secondary Cytoreduction, Medicine +7

Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20.

Andreas du Bois, Ignace Vergote, Gwénaël Ferron et al. · Journal of Clinical Oncology · 2017 · 180 citations

Gynecologic Surgery, Surgical Oncology, Secondary Cytoreductive Surgery +15

Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.

Andreas du Bois, Jalid Sehouli, Ignace Vergote et al. · Journal of Clinical Oncology · 2020 · 150 citations · Full text